Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1457506rdf:typepubmed:Citationlld:pubmed
pubmed-article:1457506lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:1457506lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:1457506lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:1457506lifeskim:mentionsumls-concept:C0205395lld:lifeskim
pubmed-article:1457506pubmed:issue5lld:pubmed
pubmed-article:1457506pubmed:dateCreated1993-1-8lld:pubmed
pubmed-article:1457506pubmed:abstractTextThe association of malignancies, such as non-Hodgkin's lymphoma and Kaposi's sarcoma, with human immunodeficiency virus infection has been recognized since the beginning of the epidemic. However, an increasing number of tumors not diagnostic of acquired immunodeficiency syndrome has been described in this setting. Taking into consideration that survival of patients with human immunodeficiency virus infection is increasing because of improvement of supportive care and better control of human immunodeficiency virus and related opportunistic infections, oncogenic viruses such as human papillomavirus, hepatitis B virus, Epstein-Barr virus, in a setting of prolonged immunosuppression could increase the risk of a variety of malignant tumors.lld:pubmed
pubmed-article:1457506pubmed:languageenglld:pubmed
pubmed-article:1457506pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1457506pubmed:citationSubsetIMlld:pubmed
pubmed-article:1457506pubmed:statusMEDLINElld:pubmed
pubmed-article:1457506pubmed:monthOctlld:pubmed
pubmed-article:1457506pubmed:issn1040-8746lld:pubmed
pubmed-article:1457506pubmed:authorpubmed-author:SpinaMMlld:pubmed
pubmed-article:1457506pubmed:authorpubmed-author:TirelliUUlld:pubmed
pubmed-article:1457506pubmed:issnTypePrintlld:pubmed
pubmed-article:1457506pubmed:volume4lld:pubmed
pubmed-article:1457506pubmed:geneSymboltatlld:pubmed
pubmed-article:1457506pubmed:ownerNLMlld:pubmed
pubmed-article:1457506pubmed:authorsCompleteYlld:pubmed
pubmed-article:1457506pubmed:pagination907-10lld:pubmed
pubmed-article:1457506pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1457506pubmed:meshHeadingpubmed-meshheading:1457506-...lld:pubmed
pubmed-article:1457506pubmed:meshHeadingpubmed-meshheading:1457506-...lld:pubmed
pubmed-article:1457506pubmed:meshHeadingpubmed-meshheading:1457506-...lld:pubmed
pubmed-article:1457506pubmed:meshHeadingpubmed-meshheading:1457506-...lld:pubmed
pubmed-article:1457506pubmed:meshHeadingpubmed-meshheading:1457506-...lld:pubmed
pubmed-article:1457506pubmed:meshHeadingpubmed-meshheading:1457506-...lld:pubmed
pubmed-article:1457506pubmed:meshHeadingpubmed-meshheading:1457506-...lld:pubmed
pubmed-article:1457506pubmed:year1992lld:pubmed
pubmed-article:1457506pubmed:articleTitleHuman immunodeficiency virus as a risk factor in miscellaneous cancers.lld:pubmed
pubmed-article:1457506pubmed:affiliationDivision of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.lld:pubmed
pubmed-article:1457506pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1457506pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1457506pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1457506lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1457506lld:pubmed